SCHEMBL6907438

SCHEMBL6907438

O=CNCC(=O)Nc1ccc(O)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 2/20 0.53
PSMB11 A5LHX3 2/20 0.48
PSMA7 O14818 2/20 0.48
PSMB1 P20618 2/20 0.48
PSMA1 P25786 2/20 0.48
PSMA2 P25787 2/20 0.48
PSMA3 P25788 2/20 0.48
PSMA4 P25789 2/20 0.48
PSMB8 P28062 2/20 0.48
PSMB9 P28065 2/20 0.48
PSMA5 P28066 2/20 0.48
PSMB4 P28070 2/20 0.48
PSMB6 P28072 2/20 0.48
PSMB5 P28074 2/20 0.48
PSMB10 P40306 2/20 0.48
PSMB3 P49720 2/20 0.48
PSMB2 P49721 2/20 0.48
PSMA6 P60900 2/20 0.48
PSMA8 Q8TAA3 2/20 0.48
PSMB7 Q99436 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5640251 0.84 GAA (0.56) ALDH1A1MEN1KMT2AGAATP53
SCHEMBL6018151 0.83 EPHX2 (0.53) ALDH1A1MEN1KMT2AMAPTCYP3A4
SCHEMBL25733674 0.82 CA12 (0.49) ALDH1A1MEN1KMT2AMAPTCA12
SCHEMBL20051422 0.82 MEN1 (0.47) MEN1KMT2ACA1CA2GAA
SCHEMBL24279669 0.80 LMNA (0.43) ALDH1A1MEN1KMT2AMAPTCA1
SCHEMBL6901558 0.80 ALDH1A1 (0.53) ALDH1A1MEN1KMT2AMAPTMAPK1
SCHEMBL19703283 0.78 ALDH1A1 (0.46) ALDH1A1MEN1KMT2AMAPTGAA
SCHEMBL6907747 0.77 GAA (0.57) ALDH1A1MEN1KMT2AMAPTTSHR
SCHEMBL19932105 0.76 CYP3A4 (0.61) ALDH1A1MEN1KMT2AMAPTCYP3A4
SCHEMBL19647199 0.76 MAPT (0.43) ALDH1A1MEN1KMT2AMAPTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6824786-B2 TOPICAL APPLYING COSMETIC YU RUEY J (US) 2004-11-30 US claimed
EP-1455734-A1 COMPOSITIONS COMPRISING PHENYL-GLYCINE DERIVATIVES Yu, Ruey J., Dr. (US) 2004-09-15 EP claimed
US-20030108496-A1 Compositions comprising phenyl-glycine derivatives YU RUEY J (US) 2003-06-12 US claimed
WO-2003045338-A1 COMPOSITIONS COMPRISING PHENYL-GLYCINE DERIVATIVES YU RUEY J (US) 2003-06-05 WO claimed
US-6824786-B2 TOPICAL APPLYING COSMETIC YU RUEY J (US) 2004-11-30 US disclosed
EP-1455734-A1 COMPOSITIONS COMPRISING PHENYL-GLYCINE DERIVATIVES Yu, Ruey J., Dr. (US) 2004-09-15 EP disclosed
US-20030108496-A1 Compositions comprising phenyl-glycine derivatives YU RUEY J (US) 2003-06-12 US disclosed
WO-2003045338-A1 COMPOSITIONS COMPRISING PHENYL-GLYCINE DERIVATIVES YU RUEY J (US) 2003-06-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030108496-A1 Compositions comprising phenyl-glycine derivatives GRHPR, ARL1, SUCLG1 CYP1A1 1470/4885PSMB11 1644/4885PSMA7 2397/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.